New Study Highlights Medtech's Quality Management Shift
A recent survey conducted by Veeva Systems, detailed in their "2025 Veeva MedTech Postmarket Quality Benchmark Report," reveals significant insights into the future of postmarket quality management within the medical technology sector. Remarkably,
88% of the surveyed companies are gearing up to enhance their postmarket quality strategies over the next three years, aligning their operations with a proactive quality culture that encourages innovation and compliance.
The Push Towards Modernization
The report indicates a pivotal shift towards modernizing quality management. As companies in the medtech field increasingly recognize the importance of quality throughout a product's lifecycle, they are setting the stage to improve compliance and minimize risks associated with manual processes. Currently,
68% of these companies still operate on a mix of manual processes, paper-based systems, or legacy solutions, hindering their ability to swiftly respond to product-related issues and complaints. This slow response not only jeopardizes patient safety but also poses significant risks to compliance and brand reputation.
Key Trends in Quality Improvement
According to the report, the essential elements driving quality improvement include:
- - Proactive and Risk-Based Quality Management (38%): Emphasizing the need for proactive approaches to handling quality issues, which enables quicker resolutions and better market adaptability.
- - Growth-Adapted Processes (26%): Adjusting operational processes to keep pace with the evolving market landscape ensures companies remain competitive and compliant.
Interestingly, the report highlights the role of technology as a facilitator in this transition. Despite over half of the companies relying on manual processes, many believe that advanced technologies can substantially enhance operational efficiency, with
75% noting that automation could lead to faster response times and streamlined workflows. Additionally,
62% acknowledge that better integration with other quality management systems is essential, while
61% emphasize the need for improved data-driven decision-making capabilities.
The Role of Emerging Technologies
Despite the looming potential of technologies like generative AI, intelligent automation, and robotic process automation (RPA), their adoption remains minimal, with less than
3% of companies effectively implementing these solutions across their organization. However, interest in these technologies is high; enhancing speed and efficiency continues to be a primary goal for most organizations.
Challenges in Employee Training
An important finding from the study is the apparent gap in employee training programs, with only
19% of respondents claiming that their current training frameworks adequately equip teams for success in postmarket quality management. This creates a timely opportunity for companies to innovate their training approaches, incorporating interactive learning methods to provide real-time updates and support to their employees.
"While initiatives are underway to streamline quality operations within medtech, this study shows many organizations are hindered by existing systems and manual processes," stated Vishaka Rajaram, Senior Director of Quality Strategy at Veeva MedTech. "By aligning strategic goals with modern technological solutions, medtech firms can pivot from reactive problem management to proactive risk prevention, paving the way for quicker operations and enhanced compliance."
Conclusion
The insights drawn from the
2025 Veeva MedTech Postmarket Quality Benchmark Report highlight not only the commitment of medical technology companies to enhance their quality management practices but also the pressing need for systemic changes in their operational frameworks. As more than 100 quality leaders in the medtech industry participated in this survey, the findings serve as a critical guide for navigating the complexities of quality management in a rapidly evolving sector.